Akili (NASDAQ:AKLI) stock is gaining on Wednesday after the company’s video game treatment showed success in reducing ADHD in adults. Akili’s EndeavorRx treatment uses video games to treat ...

Akili Interactive, which in 2020 made waves by receiving Food and Drug Administration clearance for its video game that improves symptoms of ADHD in children, on Wednesday announced it would ...

Akili made headlines in 2020 when it received Food and Drug Administration clearance for EndeavorRx, a video game designed to treat pediatric ADHD. Akili went public in 2022 in a deal that valued ...

Currently, Akili has an average volume of 2.47M. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions.

Akili to be delisted after getting acquired Before going public in 2022, digital therapeutics company Akili Inc. (Nasdaq: AKLI) raised $160 million in combined equity and debt financing.